Tilray | TRLY - Current Assets

Stock Price
10.36
Daily Change
-0.28 -2.63%
Monthly
-13.95%
Yearly
756.20%
Q1 Forecast
10.37

Tilray reported $688.63M in Current Assets for its fiscal quarter ending in March of 2025.





Current Assets Change Date
Acasti Pharma USD 17.3M 3.22M Sep/2025
Akebia Therapeutics USD 258.34M 23.68M Sep/2025
Alaunos Therapeutics USD 2.68M 1.05M Sep/2025
Aurora Cannabis CAD 423.84M 41.46M Sep/2025
Avita Medical AUD 36.25M 20.75M Jun/2025
Canopy Growth CAD 445.82M 142.46M Sep/2025
Cronos Group USD 922.15M 5M Sep/2025
Dianthus Therapeutics USD 413.82M 150.22M Sep/2025
Divis Laboratories Ltd INR 98.43B 2.38B Sep/2025
Ionis Pharmaceuticals USD 2.52B 58.16M Sep/2025
IQVIA Holdings USD 6.25B 270M Dec/2025
Knight Therapeutics CAD 397.57M 36.96M Sep/2024
Moderna USD 6.54B 54M Dec/2025
Organigram Holdings CAD 284.9M 7.11M Sep/2025
Organon & Co USD 4.7B 82M Sep/2025
Revvity USD 2.24B 95.96M Dec/2025
Tectonic Therapeutic USD 273.24M 17.61M Sep/2025
Tilray USD 688.63M 2.34M Mar/2025
Viatris USD 9.95B 176.8M Sep/2025
Xeris Pharmaceuticals USD 224.02M 38.44M Sep/2025